Imidazo[4,5-C]pyridine compound and method of antiviral treatment

Details for Australian Patent Application No. 2005319167 (hide)

Owner Gilead Sciences, Inc. Purstinger, G. K.U. Leuven Research and Development

Inventors Tse, Winston C.; Oare, David A.; Bondy, Steven S.

Agent Spruson & Ferguson

Pub. Number AU-B-2005319167

PCT Pub. Number WO2006/069193

Priority 60/638,215 21.12.04 US

Filing date 21 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 29 September 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/069193 Priority application(s): WO2006/069193

23 August 2007 Change of Name(s) of Applicant(s), Section 104

  Gilead Sciences, Inc. The name of the applicant has been changed to Gilead Sciences, Inc.; K.U. Leuven Research and Development; Purstinger, Gerhard

29 September 2011 Application Accepted

  Published as AU-B-2005319167

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005319174-Group B Streptococcus

2005319166-Reduction of hair growth with survivin inhibitors